Blog post by Stacey Tinianov and Janet Freeman-Daily On June 22nd, the American Society of Clinical Oncology (ASCO) published a conceptual framework for assessing the value of new cancer treatment options based on clinical benefit, toxicities/side effects, and cost. The document is incredibly significant for patients in that the framework allows for a person-centered patient-provider discussion […]